Page 35 - David Dodd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Почему аутсайдеры рынка — лучшее вложение Отцами-основателями направления в инвестициях, связанного с поиском недооцененных бумаг, были профессора Колумбийского университета Бенджамин Грэм и Дэвид Додд. Позднее их идеи на практике реализовали многочисленные последователи и ученики, самыми успешными из которых стали мил�...

Michael Burry is shorting Tesla stock. Here’s what I’d do now More on: Image source: Getty Images. One investor I tend to keep a close eye on is hedge fund manager Michael Burry. A little over a decade ago, Burry made an absolute fortune by successfully predicting the 2008/2009 US housing market crash and betting against subprime mortgages. His character was featured in the Hollywood blockbuster ‘ The Big Short’. Tesla stock. This means he’s betting that shares in the electric vehicle manufacturer will fall. Here, I’m going to take a closer look at Burry’s ...

The myths behind the current stock market bubble Record-low interest rates may ‘justify’ record-high stock valuations, but only in the same way that poking your eye with a stick ‘justifies’ smashing your thumb with a hammer. John Hussman Save Share The legendary value investor Benjamin Graham once advised: “The habit of relating what is paid to what is offered is an invaluable trait in investment.” Shares have sold off a bit in the last few sessions, but amid recent record highs in numerous stock market valuation measures, investors face a rare, possibly once-in-...

Capital Perspectives: Fundamental vs. technical analysis By: Chas Craig Guest Columnist May 18, 2021 Chas Craig A friend recently asked why I don’t incorporate much technical analysis (i.e. chart reading) into my investment process. For one, in theory, a weaker form of market efficiency is required for technical analysis to add value than fundamental analysis, assuming both are carried out with a similar level of competence. However, where possible, we try to be more practical than theoretical in this column. The paragraphs that follow summarize the comments I shared with my frie...

Share: At the Benzinga Global Small Cap Conference Thursday, Jason McCarthy, senior managing director at Maxim Group, hosted a panel discussion on how biotech companies are getting back to fundamentals following an extremely disruptive period during the COVID-19 pandemic. The panel discussion included Steve O’Loughlin, CFO of Actinium Pharmaceuticals Inc (NYSE: ATNM), Bill Williams, CEO of Geovax Labs Inc (NASDAQ: GOVX). Pandemic Fallout: Williams said one of the unfortunate impacts of the pandemic is that patients haven’t been coming in for regular checkups. “Unfortunately I think t...